Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Enamel hydroxyapatite crystals are the primary inorganic component of dental enamel, comprising 92–97% of its weight. They are responsible for the hardness and durability of tooth enamel. While not a direct drug target, its integrity is crucial for dental health and is influenced by various substances like fluoride.
Fluoride promotes the formation of fluorapatite, a more acid-resistant mineral. Remineralizing agents deposit calcium and phosphate ions to repair enamel.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enamel Hydroxyapatite Crystals (HA).